Freedman

#NephMadness 2017: The Case for CRISPR-Cas9

April 3, 2017 // 0 Comments

The Finalists for NephMadness 2017 have been announced! Here, Dr. Freedman makes his case for CRISPR-Cas9: Benjamin Freedman Dr. Freedman, PhD, is Assistant Professor of Medicine at the University of Washington in Seattle, WA. His laboratory [read more...]

NephMadness 2015: APOL1, The Champion

April 7, 2015 // 0 Comments

Barry I. Freedman, MD, FACP is John H. Felts, III Distinguished Professor and Chief, Section on Nephrology at Wake Forest School of Medicine. His research focuses on identifying genes underlying chronic kidney disease, type 2 diabetes mellitus, [read more...]

AJKD Blog

Official Blog of the American Journal of Kidney Diseases

Freedman

#NephMadness 2017: The Case for CRISPR-Cas9

NephMadness 2015: APOL1, The Champion